Abstract Body

Background: The isolation of broadly neutralizing HIV-1 monoclonal antibodies (mAb) to distinct epitopes on the viral envelope glycoprotein (Env) provides the potential to use combinations of mAbs for prevention and treatment of HIV-1 infection. The potency and breadth of mAb combinations have not been well characterized.

Methods: Two sets of combiantions were tested for neutralization breadth and potency on 125 viruses in TZM-bl assay. Set I includes VRC07 (CD4bs), PG9 (V1V2-glycan), PGT128 (V3-glycan) and 10E8 (MPER). Set II substituted VRC07 and PGT128 with 3BNC117 and 10-1074. In each set, 6 double, 4 triple and 1 quadruple mAb mixtures were made by combining mAbs at equal concentration. To study the interaction of mAbs, the experimental IC50 titers were compared to the titers predicted based on additive model.

Results: All combinations showed substantially improved neutralization breadth and potency compared to the corresponding single mAbs. At an IC50 cutoff of 1 μg/ml, VRC07 neutralized 83% of viruses, representing the best coverage by a single mAb, while double combinations neutralized 89-98%, and all triple and quadruple combinations neutralized 98-100%. IC50 and IC80 heat maps showed that a positive antibody in the mix enabled neutralization of strains that were resistant to the negative antibody in the mix, suggesting that the complementary neutralization profiles of the individual mAbs contributed to the improved breadth. When the experimental IC50 titers were compared to IC50 predicted based on additive model, an overall less than two fold differences were observed for all combiantions, suggesting no substantial synergy or antagonism. In 15 out of 22 combinations, including all double and triple combinations with CD4bs, V1V2-glycan and MPER mAbs, small but statistically significat increases were observed in experimetnal titers when compared to the additive prediction.

Conclusions: All 22 double, triple and quadruple combiantions containing mAbs targeting CD4bs, V1V2 glycan, V3 glycan and MPER epitpes showed substaintially improved neutralization breadth and potency. Overall the improvement was closely predicted by additive effect model and explained by complementary neutralization profiles of single mAbs. Subtle but consistent favorable interactions were observed in some mAb combinations.